Title : The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy.

Pub. Date : 2018 Dec 20

PMID : 30573703






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy. Tamoxifen phosphatase and tensin homolog Homo sapiens